Impax Asset Management Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-230,870
| Closed | -$42.4M | – | 417 |
|
|
2021
Q2 | $42.4M | Sell |
230,870
-541,779
| -70% | -$99.5M | 0.19% | 87 |
|
|
2021
Q1 | $118M | Buy |
772,649
+101,129
| +15% | +$15.5M | 0.6% | 58 |
|
|
2020
Q4 | $105M | Buy |
671,520
+20,230
| +3% | +$3.16M | 0.67% | 59 |
|
|
2020
Q3 | $74.5M | Buy |
651,290
+169,859
| +35% | +$19.4M | 0.65% | 56 |
|
|
2020
Q2 | $54M | Buy |
481,431
+85,991
| +22% | +$9.65M | 0.55% | 60 |
|
|
2020
Q1 | $35.5M | Buy |
395,440
+274,318
| +226% | +$24.6M | 0.47% | 61 |
|
|
2019
Q4 | $13.1M | Buy |
121,122
+57,861
| +91% | +$6.26M | 0.15% | 101 |
|
|
2019
Q3 | $6.2M | Buy |
+63,261
| New | +$6.2M | 0.08% | 148 |
|